Latest Earnings Analysis
-
ACMR Q4 2025: New Product Ramp Targets 25% Growth Amid Margin Headwinds
February 26, 2026 · ACMR
-
EIC Q4 2025: $45M Rotated Into Non-CLO Credit as Spread Compression Squeezes Core Returns
February 26, 2026 · EIC
-
Kodiak Gas Services (KGS) Q4 2025: Contracted Horsepower Backlog Extends Into 2028 as Lead Times Top 100 Weeks
February 26, 2026 · KGS
-
Hagerty (HGTY) Q4 2025: Written Premiums Accelerate 19% as Markel Fronting Adds Profit Leverage
February 26, 2026 · HGTY
-
MYR Group (MYRG) Q4 2025: Backlog Rises 10% as Data Center and Grid Investment Extend Growth Runway
February 26, 2026 · MYRG
-
TriMas (TRS) Q4 2025: $1.2B Aerospace Divestiture Reshapes Portfolio and Unlocks Capital Flexibility
February 26, 2026 · TRS
-
KNTK Q4 2025: 35% Delaware North Volume Surge Signals Strategic Basin Leverage
February 26, 2026 · KNTK
-
SJM Q3 2026: Coffee Margin Set for “Mid-20s%” Lift as Sweet Baked Snacks Reset Continues
February 26, 2026 · SJM
-
NWPX Q4 2025: WTS Backlog Jumps 12% as Precast Expansion Accelerates
February 26, 2026 · NWPX
-
MannKind (MNKD) Q4 2025: Furosix Sales Surge 91% as Pediatric Afrezza and Auto-Injector Catalysts Approach
February 26, 2026 · MNKD
-
Marriott Vacations (VAC) Q4 2025: $200M Asset Monetization Targets Sharpen Cash Flow Focus
February 26, 2026 · VAC
-
Novavax (NVAX) Q4 2025: R&D and SG&A Spend Slashed 53% as Matrix-M Partnerships Accelerate
February 26, 2026 · NVAX
-
Kronos Group (CRON) Q4 2025: Canada Revenue Jumps 42% as Supply Expansion Unlocks Growth
February 26, 2026 · CRON
-
Our House (ARHS) Q4 2025: Tariff Impact Narrows to $40M, Margin Resilience Holds Amid Expansion
February 26, 2026 · ARHS
-
Intellia Therapeutics (NTLA) Q4 2025: Lombosi Phase 3 Enrollment Surpasses 80, Paving Path to First CRISPR Launch
February 26, 2026 · NTLA
-
GigaCloud (GCT) Q4 2025: Europe Revenue Jumps 68%, Showcasing Playbook Scalability
February 26, 2026 · GCT
-
Warby Parker (WRBY) Q4 2025: 47 New Stores Drive 17% Retail Growth, Setting Stage for AI Glasses Launch
February 26, 2026 · WRBY
-
US Physical Therapy (USPH) Q4 2025: Hospital Alliances to Add $14M EBITDA as Margins Rebound
February 26, 2026 · USPH
-
B1 Medicines (ONC) Q4 2025: Brukinza Surges 49% as Global BTK Leadership Expands
February 26, 2026 · ONC
-
LSB Industries (LXU) Q4 2025: EBITDA Climbs 42% on Downstream Shift and Tight Nitrogen Markets
February 26, 2026 · LXU
-
Catalyst Pharmaceuticals (CPRX) Q4 2025: Agamri Surges 154%, Expanding Rare Disease Franchise
February 26, 2026 · CPRX
-
Collegium Pharmaceutical (COLL) Q4 2025: Journée PM Revenue Surges 48%, Anchoring Portfolio Diversification
February 26, 2026 · COLL
-
Krispy Kreme (DNUT) Q4 2025: Adjusted EBITDA Surges 21% as Refranchising and Cost Cuts Reshape Model
February 26, 2026 · DNUT
-
Arbe (ARBE) Q4 2025: Non-Auto Pipeline Drives $4–6M Outlook as Defense Orders Accelerate
February 26, 2026 · ARBE
-
Shake Shack (SHAK) Q4 2025: Build Costs Down 20%, Margin Expansion Signals Durable Growth Path
February 26, 2026 · SHAK
-
Titan International (TWI) Q4 2025: EMC Segment Jumps 21% as Global Infrastructure Demand Fuels Recovery
February 26, 2026 · TWI
-
Playtika (PLTK) Q4 2025: D2C Revenue Surges 43% as SuperPlay Drives Portfolio Shift
February 26, 2026 · PLTK
-
California Water Service Group (CWT) Q4 2025: $517M CapEx Push Drives 12% Rate Base Growth Path
February 26, 2026 · CWT
-
FTI Consulting (FCN) Q4 2025: CorpFin Surges 26%, Offsetting $100M Segment EBITDA Headwind
February 26, 2026 · FCN
-
Diana Shipping (DSX) Q4 2025: 76% of 2026 Days Locked at $17,670, Securing Revenue Amid Fleet Renewal
February 26, 2026 · DSX
-
Crescent Capital BDC (CCAP) Q4 2025: Non-Accruals Rise to 4.1% as Portfolio Diversification Anchors Stability
February 26, 2026 · CCAP
-
SVC Q4 2025: $745M Net Lease Refi Cuts Interest Costs, Drives Portfolio Shift
February 26, 2026 · SVC
-
Vistra (VST) Q4 2025: Nuclear PPAs Add 3.8 GW, Reshaping Long-Term Earnings Mix
February 26, 2026 · VST
-
Privia Health (PRVA) Q4 2025: EBITDA Margin Expands 480bps, Signaling Sustainable Cash Compounding
February 26, 2026 · PRVA
-
NOG (NOG) Q4 2025: Gas Volumes Up 24% as Portfolio Diversification Drives Resilience
February 26, 2026 · NOG
-
FSK (FSK) Q4 2025: Non-Accruals Climb to 5.5% of Cost, Heightening Portfolio Volatility
February 26, 2026 · FSK
-
Carlyle Credit Income Fund (CCIF) Q1 2026: CLO Yield Drops to 13.6% as Spread Compression Squeezes Returns
February 26, 2026 · CCIF
-
Public Service Enterprise Group (PEG) Q4 2025: Capital Plan Lifts to $28B, Raising Long-Term Growth Outlook
February 26, 2026 · PEG
-
Middleby (MIDD) Q4 2025: 9% Share Count Cut Reshapes Focus as Food Processing Backlog Jumps 36%
February 26, 2026 · MIDD
-
TG Therapeutics (TGTX) Q4 2025: Brionvi Franchise Grows 92% as Subcutaneous Launch Nears
February 26, 2026 · TGTX
-
Charles River Associates (CRAI) Q4 2025: Antitrust and Forensics Surge 20%+ as Talent Investments Hit $88M
February 26, 2026 · CRAI
-
CrossAmerica Partners (CAPL) Q4 2025: Asset Sales Top $100M, Fueling Debt Reduction and Margin Gains
February 26, 2026 · CAPL
-
Ramaco Resources (METC) Q4 2025: Liquidity Surges 275% as Flow Sheet Pivot Recasts Critical Minerals Trajectory
February 26, 2026 · METC
-
EW Scripps (SSP) Q4 2025: Transformation Plan Targets $150M EBITDA Lift, Sports and Core Ads Drive Momentum
February 26, 2026 · SSP
-
Kimbell Royalty Partners (KRP) Q4 2025: Permian Drives 8% Reserve Growth as Line-of-Sight Wells Surpass Maintenance Levels
February 26, 2026 · KRP
-
FIHL (FIHL) Q4 2025: Share Repurchases Add $1.24 to Book Value, Capital Allocation Drives Outperformance
February 26, 2026 · FIHL
-
Universal Health Services (UHS) Q4 2025: Behavioral Outpatient Expands 10% of Segment Revenue as Pricing Moderates
February 26, 2026 · UHS
-
Churchill Downs (CHDN) Q4 2025: Derby Week Expansion Drives $15–$20M EBITDA Upside
February 26, 2026 · CHDN
-
Pebblebrook Hotel Trust (PEB) Q4 2025: Resort EBITDA Jumps 17% as Urban Recovery Accelerates
February 26, 2026 · PEB
-
ChemEd (CHE) Q4 2025: Roto-Rooter Paid Leads Up 9.4% as Digital Mix Reshapes Margin Trajectory
February 26, 2026 · CHE